The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...

Add Yahoo as a preferred source to see more of our stories on Google. Warning issued as prostate cancer patients ‘missing out’ on life-extending care Some prostate cancer patients are “missing out” on ...

Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a significant expansion of eligibility criteria. Previously, the hormone therapy ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

U.S. Senator John Boozman (R-AR) was recognized for his leadership in advancing policiies that prioritize enhanced care and research for prostate cancer.